NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.38
-2.09 (-10.21%)
At close: Apr 1, 2025, 4:00 PM
18.78
+0.40 (2.18%)
After-hours: Apr 1, 2025, 5:29 PM EDT

NAMS Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
771.74340.45467.7360.387.86
Short-Term Investments
62.45----
Cash & Short-Term Investments
834.19340.45467.7360.387.86
Cash Growth
145.03%-27.21%674.64%668.09%-
Other Receivables
21.311.882.074.88-
Receivables
21.311.882.074.88-
Prepaid Expenses
7.924.468.181.71.36
Total Current Assets
863.41346.79477.9866.969.22
Property, Plant & Equipment
0.670.10.150.220.01
Other Intangible Assets
0.530.170.21--
Other Long-Term Assets
-0.040.16--
Total Assets
864.62347.1478.567.999.23
Accounts Payable
4.7416.9211.857.070.4
Accrued Expenses
13.6111.46.124.10.76
Short-Term Debt
----11.65
Current Portion of Leases
0.250.060.070.06-
Current Unearned Revenue
6.018.9413.87--
Other Current Liabilities
82.3112.574.15--
Total Current Liabilities
106.9249.936.0611.2412.81
Long-Term Leases
0.2-0.060.13-
Long-Term Unearned Revenue
-1.024.79--
Other Long-Term Liabilities
-7.797.52--
Total Liabilities
107.1258.748.4311.3612.81
Common Stock
13.4410.1710.060.130.05
Additional Paid-In Capital
1,298590.77555.6395.262.45
Retained Earnings
-558.57-316.97-140.04-39.44-6.08
Comprehensive Income & Other
4.474.424.420.67-
Shareholders' Equity
757.5288.39430.0756.63-3.58
Total Liabilities & Equity
864.62347.1478.567.999.23
Total Debt
0.450.060.130.1911.65
Net Cash (Debt)
833.74340.39467.660.19-3.79
Net Cash Growth
144.94%-27.21%676.83%--
Net Cash Per Share
8.844.1424.655.48-0.76
Filing Date Shares Outstanding
109.8289.2781.7711.335
Total Common Shares Outstanding
108.0682.4781.5611.335
Working Capital
756.5296.89441.9255.72-3.59
Book Value Per Share
7.013.505.275.00-0.72
Tangible Book Value
756.97288.22429.8656.63-3.58
Tangible Book Value Per Share
7.003.495.275.00-0.72
Machinery
---0.040.01
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q